MyJournals Home  

RSS FeedsMelphalan dose in myeloma patients >=65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study (Bone Marrow Transplantation)

 
 

5 november 2018 00:00:09

 
Melphalan dose in myeloma patients >=65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study (Bone Marrow Transplantation)
 






Del.icio.us Digg Facebook Google StumbleUpon Twitter
 
473 viewsCategory: Medicine, Pathology
 
Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantation (Bone Marrow Transplantation)
Successful engraftment in recipients of haploidentical stem cells with donor-specific antibodies: role of flow cytometric cross-match (Bone Marrow Transplantation)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pathology

Use these buttons to bookmark us:
Del.icio.us Digg Facebook Google StumbleUpon Twitter


Valid HTML 4.01 Transitional
Copyright © 2008 - 2018 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Travel Photos Nachrichten Indigonet Finances Leer Mandarijn